Organogenesis Revenue and Competitors
Estimated Revenue & Valuation
- Organogenesis's estimated annual revenue is currently $175.9M per year.
- Organogenesis received $100.0M in venture funding in March 2019.
- Organogenesis's estimated revenue per employee is $177,165
- Organogenesis's total funding is $375M.
Employee Data
- Organogenesis has 993 Employees.
- Organogenesis grew their employee count by -1% last year.
Organogenesis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Organogenesis?
Headquartered in Canton, Massachusetts, Organogenesis Inc. is a global leader in regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis versatile portfolio is designed to treat a variety of patients with repair and regenerative needs.
keywords:Biotechnology,Consulting and Research,Healthcare,Medical Devices,Pharmaceuticals
$375M
Total Funding
993
Number of Employees
$175.9M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Organogenesis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | VP and General Counsel | Reveal Email/Phone |
3 | VP Regulatory Affairs | Reveal Email/Phone |
4 | Systems Administrator III | Reveal Email/Phone |
5 | VP, Customer Experience | Reveal Email/Phone |
6 | VP, Quality Systems | Reveal Email/Phone |
7 | Manager, QC Materials and Cell Banks | Reveal Email/Phone |
8 | QA Specialist | Reveal Email/Phone |
9 | Engineering Manager, Facilities and Controls | Reveal Email/Phone |
10 | Chief Financial Officer | Reveal Email/Phone |
Organogenesis News
- April 21, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Organogenesis Holdings Inc. ORGO...
It also takes a look at the major industry vendors who are currently available. Organogenesis; Tissue Regenix Group; AlloSource. ACCESS FULL...
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring 2022 Conference. April 05, 2022 16:30 ET | Source: Organogenesis...
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today annou ...
Avista Healthcare Public Acquisition Corp. (NASDAQ :AHPA ), a publicly traded special purpose acquisition company, and Organogenesis Inc. a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgic ...
Other Companies in Canton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $219.9M | 1094 | 7% | N/A |
#2 | $277.7M | 1102 | N/A | N/A |
#3 | $504.6M | 1335 | -8% | N/A |
#4 | $367.2M | 1457 | 4% | N/A |
#5 | $762.1M | 1542 | N/A | N/A |
Organogenesis Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2001-10-17 | $20.2M | Late Stage | Article | |
| 2002-03-22 | $16.0M | Private Placement | Article | |
| 2016-04-15 | $30.0M | Undisclosed | Article | |
| 2017-04-11 | $25.0M | Undisclosed | Silicon Valley Bank | Article |
| 2017-05-23 | $20.0M | Undisclosed | Eastward Capital Partners | Article |
| 2019-03-15 | $100.0M | Undisclosed | Silicon Valley Bank | Article |